Results 81 to 90 of about 3,352 (104)

A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects

Clinical Therapeutics, 2016
Xavier PIVOT, Rainard Fuhr
exaly  

Trastuzumab/trastuzumab-deruxtecan

Reactions Weekly
openaire   +1 more source

Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms

Trends in Pharmacological Sciences, 2015
Charles Guenancia, , Marianne Zeller
exaly  

Trastuzumab/trastuzumab-emtansine

Reactions Weekly
openaire   +1 more source

Mechanisms of Trastuzumab Resistance and Their Clinical Implications

Annals of the New York Academy of Sciences, 2005
Dihua Yu, Chien-Hsing Lu, Keng-Hsueh Lan   +2 more
exaly  

“Trastuzumab”

IIC - International Review of Intellectual Property and Competition Law, 2023
openaire   +1 more source

Trastuzumab

Reactions Weekly, 2017
openaire   +2 more sources

Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor

Cancer Letters, 2008
Jorma Isola, Peter Nagy, György Vereb   +2 more
exaly  

Emtansine/pertuzumab/trastuzumab/trastuzumab

Reactions Weekly
openaire   +1 more source

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Annals of Oncology, 2018
Paolo Pronzato, Michele Aieta, Antonio Russo   +2 more
exaly